Lexicon Pharmaceuticals | LXRX - Stock

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $168K in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Abbott USD 6.71B 246M Sep/2025
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Akebia Therapeutics USD 18.64M 1.93M Sep/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Coherus Biosciences USD 2.05M 2.46M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Illumina USD 564M 26M Dec/2025
Insmed USD 120.96M 13.36M Sep/2025
J&J USD 14.19B 45M Dec/2025
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
MacroGenics USD 8.75M 530K Sep/2025
MannKind USD 26.97M 1.52M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025